Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$41.04 - $56.79 $952,128 - $1.32 Million
-23,200 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$36.42 - $57.0 $456,233 - $714,039
-12,527 Reduced 35.06%
23,200 $957,000
Q2 2020

Aug 14, 2020

BUY
$39.26 - $52.73 $1.4 Million - $1.88 Million
35,727 New
35,727 $1.73 Million
Q4 2019

Feb 13, 2020

SELL
$36.21 - $51.4 $1.11 Million - $1.57 Million
-30,600 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$22.22 - $44.01 $679,932 - $1.35 Million
30,600 New
30,600 $1.1 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.73B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.